XBI
ETF
Biotechnology
NYSEARCA
SPDR S&P Biotech ETF
$157.87
+1.32 (+0.84%)
Fund Overview
by SPDR (State Street)
Equal-weighted biotech ETF. Gives small-cap clinical-stage biotech companies equal weight with large-cap pharma-like biotechs, creating a higher risk/reward profile. When biotech M&A heats up, XBI often outperforms.
AUM$6.5B
Expense Ratio0.35%
Holdings145
Dividend Yield0.1%
DistributionQuarterly
BenchmarkS&P Biotechnology Select Industry Index
InceptionJan 2006
ExchangeNYSEARCA
Price Data
Open$157.51
Prev Close$156.55
Day Range$156.48 — $160.82
52W Range$66.66 — $132.09
52-Week Range
$66.66
$132.09
From 52W High
19.5%
From 52W Low
+136.8%
Investment Calculator
See how much dividend income XBI could generate based on its current price of $157.87 and 0.1% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,945.81
Annual Income$9.95
Monthly Income$0.83
Based on current dividend yield of 0.1%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $254.76 | -2.42% | 461.26B |
| AMGN | $366.44 | -2.06% | 201.93B |
| GILD | $129.61 | -1.26% | 162.98B |
| VRTX | $529.59 | +0.29% | 131.79B |
| REGN | $649.81 | -0.68% | 68.59B |
| ALNY | $313.04 | +0.08% | 41.76B |
| RVMD | $189.99 | +0.40% | 40.23B |
| NTRA | $283.80 | +1.60% | 40.00B |
| BIIB | $208.46 | -3.54% | 31.91B |
| MRNA | $81.80 | +2.56% | 31.65B |
XBI FAQ
What is XBI?
XBI is the SPDR S&P Biotech ETF, an exchange-traded fund managed by SPDR (State Street). It tracks the S&P Biotechnology Select Industry Index and holds 145 Biotechnology securities with an expense ratio of 0.35%.
What is the expense ratio of XBI?
XBI charges an annual expense ratio of 0.35%, which means you pay $35.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does XBI pay dividends?
Yes, XBI pays a 0.1% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $10.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Jul 2, 2026 at 5:00 PM ET